Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D Holliday

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|July 31, 2012
The arginine of the DRY motif in transmembrane segment III functions as a balancing micro-switch in the activation of the β2-adrenergic receptorLouise Valentin-Hansen, Marleen Groenen, Rie Nygaard, et al.
Plos One|October 13, 2011
Dimerization of ABCG2 analysed by bimolecular fluorescence complementationAmeena J Haider, Deborah Briggs, Tim J Self, et al.
Organic & Biomolecular Chemistry|April 16, 2014
Synthetic routes to the Neuropeptide Y Y1 receptor antagonist 1229U91 and related analogues for SAR studies and cell-based imagingSimon J Mountford, Mengjie Liu, Lei Zhang, et al.
Molecular Pharmacology|November 8, 2007
Characterization of G-protein coupled receptor kinase interaction with the neurokinin-1 receptor using bioluminescence resonance energy transferRasmus Jorgensen, Nicholas D Holliday, Jakob L Hansen, et al.
Nucleic Acids Research|May 6, 2011
Dimer formation and conformational flexibility ensure cytoplasmic stability and nuclear accumulation of Elk-1Emma L Evans, Janice Saxton, Samuel J Shelton, et al.
Journal of Medicinal Chemistry|May 5, 2020
Heterodimeric Analogues of the Potent Y1R Antagonist 1229U91, Lacking One of the Pharmacophoric C-Terminal Structures, Retain Potent Y1R Affinity and Show Improved Selectivity over Y4RRachel R Richardson, Marleen Groenen, Mengjie Liu, et al.
Cellular Immunology|July 1, 2026
The uptake, intracellular trafficking and recycling of FcRn-blocking therapeutics in human endothelial cells in vitroJulija Sirina, Lena E D'Hooghe, Laura A Singhvi-Hanns, et al.
Bioconjugate Chemistry|August 12, 2016
Identification of a Cyanine-Dye Labeled Peptidic Ligand for Y1R and Y4R, Based upon the Neuropeptide Y C-Terminal Analogue, BVD-15Mengjie Liu, Rachel R Richardson, Simon J Mountford, et al.
Pharmacology Research & Perspectives|February 9, 2024
Role of G protein-coupled receptor kinases (GRKs) in β<sub>2</sub> -adrenoceptor-mediated glucose uptakeSeungmin Ham, Saori Mukaida, Masaaki Sato, et al.
Archives of Biochemistry and Biophysics|February 2, 2024
A time-resolved Förster resonance energy transfer assay to investigate drug and inhibitor binding to ABCG2James I Mitchell-White, Deborah A Briggs, Sarah J Mistry, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|July 31, 2012
The arginine of the DRY motif in transmembrane segment III functions as a balancing micro-switch in the activation of the β2-adrenergic receptorLouise Valentin-Hansen, Marleen Groenen, Rie Nygaard, et al.
Plos One|October 13, 2011
Dimerization of ABCG2 analysed by bimolecular fluorescence complementationAmeena J Haider, Deborah Briggs, Tim J Self, et al.
Organic & Biomolecular Chemistry|April 16, 2014
Synthetic routes to the Neuropeptide Y Y1 receptor antagonist 1229U91 and related analogues for SAR studies and cell-based imagingSimon J Mountford, Mengjie Liu, Lei Zhang, et al.
Molecular Pharmacology|November 8, 2007
Characterization of G-protein coupled receptor kinase interaction with the neurokinin-1 receptor using bioluminescence resonance energy transferRasmus Jorgensen, Nicholas D Holliday, Jakob L Hansen, et al.
Nucleic Acids Research|May 6, 2011
Dimer formation and conformational flexibility ensure cytoplasmic stability and nuclear accumulation of Elk-1Emma L Evans, Janice Saxton, Samuel J Shelton, et al.
Journal of Medicinal Chemistry|May 5, 2020
Heterodimeric Analogues of the Potent Y1R Antagonist 1229U91, Lacking One of the Pharmacophoric C-Terminal Structures, Retain Potent Y1R Affinity and Show Improved Selectivity over Y4RRachel R Richardson, Marleen Groenen, Mengjie Liu, et al.
Cellular Immunology|July 1, 2026
The uptake, intracellular trafficking and recycling of FcRn-blocking therapeutics in human endothelial cells in vitroJulija Sirina, Lena E D'Hooghe, Laura A Singhvi-Hanns, et al.
Bioconjugate Chemistry|August 12, 2016
Identification of a Cyanine-Dye Labeled Peptidic Ligand for Y1R and Y4R, Based upon the Neuropeptide Y C-Terminal Analogue, BVD-15Mengjie Liu, Rachel R Richardson, Simon J Mountford, et al.
Pharmacology Research & Perspectives|February 9, 2024
Role of G protein-coupled receptor kinases (GRKs) in β<sub>2</sub> -adrenoceptor-mediated glucose uptakeSeungmin Ham, Saori Mukaida, Masaaki Sato, et al.
Archives of Biochemistry and Biophysics|February 2, 2024
A time-resolved Förster resonance energy transfer assay to investigate drug and inhibitor binding to ABCG2James I Mitchell-White, Deborah A Briggs, Sarah J Mistry, et al.
Pageof 5